.
MergerLinks Header Logo

New Deal


Announced

Completed

Apposite Capital completed the acquisition of a majority stake in CrestOptics.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Cross Border

Medical Supplies

Acquisition

Majority

Private

Friendly

Italy

Single Bidder

healthcare technology

Private Equity

Completed

Synopsis

Edit

Apposite Capital, a private equity firm, completed the acquisition of a majority stake in CrestOptics, a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications. Financial terms were not disclosed. “This agreement demonstrates that CrestOptics is an established brand and a strong player in the worldwide microscopy market. Strategic collaborations with external partners such as Apposite Capital LLP will help us further enforce our market positioning and strengthen our product portfolio with other innovative technologies. Apposite and CrestOptics share the same vision for the future and see huge potential for growth," Renato Giacobbo Scavo, CrestOptics CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US